Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients

Ann Neurol. 2001 Nov;50(5):686-7. doi: 10.1002/ana.1267.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Aged
  • Analysis of Variance
  • Anti-Bacterial Agents
  • Anti-Ulcer Agents / therapeutic use
  • Area Under Curve
  • Biological Availability
  • Drug Therapy, Combination / therapeutic use
  • Helicobacter Infections / blood
  • Helicobacter Infections / complications
  • Helicobacter Infections / diagnosis*
  • Helicobacter Infections / drug therapy*
  • Humans
  • Intestinal Absorption / drug effects
  • Levodopa / administration & dosage
  • Levodopa / blood
  • Levodopa / pharmacokinetics*
  • Omeprazole / therapeutic use
  • Parkinson Disease / blood
  • Parkinson Disease / complications
  • Parkinson Disease / diagnosis*
  • Parkinson Disease / drug therapy*
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Anti-Ulcer Agents
  • Levodopa
  • Omeprazole

Grants and funding